The Behavioral Effects of Combination Therapy of Memantine and Acetylcholinesterase Inhibitors Compared with Acetylcholinesterase Inhibitors Alone in Patients with Moderate Alzheimer’s Dementia: A Double-Blind Randomized Placebo-Controlled Trial

키워드

참고문헌 (43)

1. Xu J, "Biomarkers for Preclinical Alzheimer’s Disease", pp.3~13 (2018), Springer
2. Ji Won Han, "Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia", PSYCHIATRY INVESTIGATION, 15(8), pp.767~774 (2018), 대한신경정신의학회[DOI]
3. Korean Dementia Observatory 2019, "National Institute of Dementia", National Institute of Dementia, ~ (2020)
4. Beeri MS, "The cost of behavioral and psychological symptoms of dementia(BPSD)in community dwelling Alzheimer’s disease patients", Int J Geriatr Psychiatry, 17, pp.403~408 (2002)
5. Lowery D, "Behavioural and psychological symptoms of dementia(BPSD) : the personal and practical costs of dementia", J Integr Care, 17, pp.13~19 (2009)
6. Olazaran-Rodriguez J, "Psychological and behavioural symptoms of dementia : prevention, diagnosis and treatment", Rev Neurol, 55, pp.598~608 (2012)
7. Teri L, "Behavior and caregiver burden : behavioral problems in patients with Alzheimer disease and its association with caregiver distress", Alzheimer Dis Assoc Disord, 11(Suppl 4), pp.S35~S38 (1997)
8. 윤현철, "치매의 약물요법", 대한의사협회지, 61(12), pp.758~764 (2018), 대한의사협회[DOI]
9. Trinh NH, "Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease : a meta-analysis", JAMA, 289, pp.210~216 (2003)
10. Azermai M, "Dealing with behavioral and psychological symptoms of dementia : a general overview", Psychol Res Behav Manag, 8, pp.181~185 (2015)
11. Wang F, "Drug Therapy for Behavioral and Psychological Symptoms of Dementia", Curr Neuropharmacol, 14, pp.307~313 (2016)
12. Bains J, "Antidepressants for treating depression in dementia", Cochrane Database Syst Rev, 4, pp.CD003944~ (2002)
13. Tampi RR, "Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia : a systematic review of randomized controlled trials", Am J Alzheimers Dis Other Demen, 29, pp.565~574 (2014)
14. "Encephale", 2008, 409~415
15. Rogawski MA, "The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease", CNS Drug Rev, 9, pp.275~308 (2003)
16. McShane R, "Memantine for dementia", Cochrane Database Syst Rev, 2, pp.CD003154~ (2006)
17. Winblad B, "Memantine in moderate to severe Alzheimer’s disease : a meta-analysis of randomised clinical trials", Dement Geriatr Cogn Disord, 24, pp.20~27 (2007)
18. Johnson JW, "Mechanism of action of memantine", Curr Opin Pharmacol, 6, pp.61~67 (2006)
19. Parsons CG, "Memantine and cholinesterase inhibitors : complementary mechanisms in the treatment of Alzheimer’s disease", Neurotox Res, 24, pp.358~369 (2013)
20. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders: DSM-5TM" (2013), American Psychiatric Publishing, Inc
21. Folstein MF, ""Mini-mental state". A practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
22. 이동영, "Mini-Mental State Examination의 한국 노인 정상규준 연구", 신경정신의학, 41(3), pp.508~525 (2002), 대한신경정신의학회
23. Cummings JL, "The Neuropsychiatric Inventory : comprehensive assessment of psychopathology in dementia", Neurology, 44, pp.2308~2314 (1994)
24. Choi SH, "The Korean version of the neuropsychiatric inventory : a scoring tool for neuropsychiatric disturbance in dementia patients", J Korean Med Sci, 15, pp.609~615 (2000)
25. Reisberg B, "Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines", Alzheimer Dis Assoc Disord, 11(Suppl 3), pp.8~18 (1997)
26. Gottfries CG, "A new rating scale for dementia syndromes", Arch Gerontol Geriatr, 1, pp.311~330 (1982)
27. Zarit SH, "Subjective burden of husbands and wives as caregivers : a longitudinal study", Gerontologist, 26, pp.260~266 (1986)
28. 배경열, "노인의 인지기능에 따른 부양자의 부양부담", 생물치료정신의학, 12(1), pp.66~75 (2006), 대한생물치료정신의학회
29. Youn H, "Obstetric risk factors for depression during the postpartum period in South Korea : a nationwide study", J Psychosom Res, 102, pp.15~20 (2017)
30. Margallo-Lana M, "Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments", Int J Geriatr Psychiatry, 16, pp.39~44 (2001)
31. Haibo X, "Prevalence and severity of behavioral and psychological symptoms of dementia(BPSD)in community dwelling Chinese : findings from the Shanghai three districts study", Aging Ment Health, 17, pp.748~752 (2013)
32. van der Linde RM, "Longitudinal course of behavioural and psychological symptoms of dementia : systematic review", Br J Psychiatry, 209, pp.366~377 (2016)
33. Tariot PN, "Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil : a randomized controlled trial", JAMA, 291, pp.317~324 (2004)
34. Grossberg GT, "The safety, tolerability, and efficacy of once-daily memantine(28 mg) : a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer’s disease taking cholinesterase inhibitors", CNS Drugs, 27, pp.469~478 (2013)
35. Porsteinsson AP, "Memantine treatment in patients with mild to moderate Alzheimer’s disease already receiving a cholinesterase inhibitor : a randomized, double-blind, placebo-controlled trial", Curr Alzheimer Res, 5, pp.83~89 (2008)
36. Choi SH, "Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer’s disease : a multicenter, randomized, open-label, parallel-group study", Curr Med Res Opin, 27, pp.1375~1383 (2011)
37. Carotenuto A, "The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer’s Disease : Interim Results of the ASCOMALVA Trial", J Alzheimers Dis, 56, pp.805~815 (2017)
38. Starkstein SE, "Prevalence and clinical correlates of disinhibition in dementia", Cogn Behav Neurol, 17, pp.139~147 (2004)
39. Povysheva NV, "Effects of memantine on the excitation-inhibition balance in prefrontal cortex", Neurobiol Dis, 96, pp.75~83 (2016)
40. Araki T, "The effects of combine treatment of memantine and donepezil on Alzheimer’s disease patients and its relationship with cerebral blood flow in the prefrontal area", Int J Geriatr Psychiatry, 29, pp.881~889 (2014)
41. Zamboni G, "Apathy and disinhibition in frontotemporal dementia : Insights into their neural correlates", Neurology, 71, pp.736~742 (2008)
42. Lyketsos CG, "Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment : results from the cardiovascular health study", JAMA, 288, pp.1475~1483 (2002)
43. Kaufer DI, "Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory", J Neuropsychiatry Clin Neurosci, 12, pp.233~239 (2000)

관련 논문AI추천